サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1787016

対照薬調達市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、地域別、2025年～2034年の市場予測

Comparator Drug Sourcing Market Size, Share, Trends, & Industry Analysis Report By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
対照薬調達市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、地域別、2025年～2034年の市場予測
出版日: 2025年07月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、対照薬調達市場規模は2034年までに22億2,000万米ドルに達する見込みです。本レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

対照薬調達は、既存の標準治療に対する新規治療薬の安全性と有効性を評価する臨床試験において不可欠です。これらの薬剤は、規制遵守、バッチのトレーサビリティ、治験実施施設へのタイムリーな世界デリバリーを保証する専門プロバイダーを通じて調達されます。

市場成長の主な原動力は、世界の臨床試験件数の増加と、薬剤のトレーサビリティや品質コンプライアンスに関する規制当局の監視強化です。製薬スポンサーや医薬品開発業務受託機関（CRO）のサービスでは、集中型およびローカライズ型の調達モデルを提供し、供給の継続性、ドキュメンテーションの正確性、国境を越えたコンプライアンスを確保するソーシング・パートナーへの依存度が高まっています。

対照薬調達市場レポートハイライト

タイプ別では、調達の標準化、法規制コンプライアンスの改善、大規模第III相臨床試験のサポートが可能な中央調達セグメントが2024年の市場を独占しました。

用途別では、製造受託機関（CMO）分野が2024年の市場を独占しました。この背景には、臨床試験のアウトソーシングの増加や、契約ベースの臨床実施におけるターンキー・ソーシング・ソリューションのニーズがあります。

北米は、臨床試験量の多さ、厳格なFDAコンプライアンス要件、集中型ソーシングモデルへの強い依存によって、2024年の世界の対照薬調達市場の大半のシェアを占めました。

アジア太平洋地域は、臨床試験の拡大、コスト優位性、地域インフラの成長により、大きな市場シェアを占めています。

世界の主要市場プレーヤーには、Thermo Fisher Scientific Inc.、Clinigen Limited、Inceptua Group、Uniphar Clinical、Catalent, Inc.、Clinical Services International（CSI）、BAP Pharma Limited、Oximio、Bionical Emas、Alcura、Myonex、Cencora, Inc.、Sharp Services, LLC、ADAllen Pharma、RxSolutions部門などがあります。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界対照薬調達市場の洞察

  • 市場スナップショット
  • 対照薬調達市場力学
    • 促進要因と機会
      • 増加する世界の臨床試験
      • 厳格な規制要件
    • 抑制要因と課題
      • 温度管理物流に伴う高い運用コスト
  • PESTEL分析
  • 対照薬調達市場の動向
  • バリューチェーン分析

第5章 世界の対照薬調達市場：タイプ別

  • 主な調査結果
  • イントロダクション
  • 中央調達
  • 現地調達
  • その他のタイプ

第6章 世界対照薬調達市場：用途別

  • 主な調査結果
  • イントロダクション
  • 医薬品製造業者
  • 受託製造組織（CMO）
  • 学術研究機関
  • その他の用途

第7章 世界の対照薬調達市場：地域別

  • 主な調査結果
  • イントロダクション
    • 対照薬調達市場評価：地域別、2020～2034年
  • 北米
    • 北米：タイプ別、2020～2034年
    • 北米：用途別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：タイプ別、2020～2034年
    • 欧州：用途別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域：タイプ別、2020～2034年
    • アジア太平洋地域：用途別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：タイプ別、2020～2034年
    • 中東・アフリカ：用途別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：タイプ別、2020-2034年
    • ラテンアメリカ：用途別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Alcura
  • ADAllen Pharma
  • BAP Pharma Limited
  • Bionical Emas
  • Catalent, Inc.
  • Cencora, Inc.
  • Clinical Services International（CSI）
  • Clinigen Limited
  • Inceptua Group
  • Myonex
  • Oximio
  • RxSolutions division
  • Sharp Services, LLC
  • Thermo Fisher Scientific Inc.
  • Uniphar Clinical
図表

List of Tables:

  • Table 1 Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 3 North America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 4 North America: Comparator Drug Sourcing Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 U.S.: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 6 U.S.: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 7 Canada: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 8 Canada: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 9 Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 10 Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 11 UK: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 12 UK: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 13 France: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 14 France: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Germany: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 16 Germany: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Italy: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Italy: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 19 Spain: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Spain: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 23 Russia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Russia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 29 China: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 30 China: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 31 India: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 32 India: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 35 Japan: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Japan: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 39 South Korea: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 40 South Korea: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Australia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Australia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 49 UAE: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 50 UAE: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Israel: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Israel: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 53 South Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 54 South Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 59 Mexico: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 60 Mexico: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Brazil: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Brazil: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Argentina: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 64 Argentina: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Comparator Drug Sourcing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Comparator Drug Sourcing Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Comparator Drug Sourcing Market, by Application, 2024 & 2034 (USD Billion)
目次
Product Code: PM5971

The comparator drug sourcing market size is expected to reach USD 2.22 Billion by 2034, according to a new study by Polaris Market Research. The report "Comparator Drug Sourcing Market Share, Size, Trends, Industry Analysis Report: By Type (Local Sourcing, Central Sourcing, and Market Sourcing), By Application, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Comparator drugs are essential in clinical trials to evaluate the safety and efficacy of new therapeutics against existing standards of care. These drugs are sourced through specialized providers that ensure regulatory compliance, batch traceability, and timely global delivery across trial sites.

Market growth is primarily driven by the rising number of global clinical trials globally coupled with growing regulatory scrutiny around drug traceability and quality compliance. Pharmaceutical sponsors and contract research organization (CROs) services are increasingly relying on sourcing partners that offer centralized and localized procurement models, ensuring supply continuity, documentation accuracy, and cross-border compliance.

Comparator Drug Sourcing Market Report Highlights

Based on type, the central sourcing segment dominated the market in 2024, owing to its ability to standardize procurement, improve regulatory compliance, and support large-scale Phase III clinical trials.

In terms of application, the contract manufacturing organizations (CMO) segment dominated the market in 2024. This is fueled by increasing trial outsourcing and the need for turnkey sourcing solutions within contract-based clinical execution.

North America accounted for the majority share of the global comparator drug sourcing market in 2024, fueled by high clinical trial volume, stringent FDA compliance requirements and strong reliance on centralized sourcing models.

Asia Pacific held significant market share, driven by expanding trial activity, cost advantages, and growing regional infrastructure.

A few global key market players include Thermo Fisher Scientific Inc., Clinigen Limited, Inceptua Group, Uniphar Clinical, Catalent, Inc, Clinical Services International (CSI), BAP Pharma Limited, Oximio, Bionical Emas, Alcura, Myonex, Cencora, Inc., Sharp Services, LLC, ADAllen Pharma, and RxSolutions division.

Polaris Market Research has segmented the market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Central Sourcing

Local Sourcing

Other Types

By Application Outlook (Revenue, USD Billion, 2020-2034)

Drug Producers/Manufacturers

Contract Manufacturing Organizations (CMO)

Academic and Research Institute

Other Applications

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Comparator Drug Sourcing Market Insights

  • 4.1. Comparator Drug Sourcing Market - Market Snapshot
  • 4.2. Comparator Drug Sourcing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Number of Global Clinical Trials
      • 4.2.1.2. Stringent Regulatory Requirements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Operational Costs Associated with Temperature-Controlled Logistics
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Comparator Drug Sourcing Market Trends
  • 4.6. Value Chain Analysis

5. Global Comparator Drug Sourcing Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Central Sourcing
    • 5.3.1. Global Comparator Drug Sourcing Market, by Central Sourcing, by Region, 2020-2034 (USD Billion)
  • 5.4. Local Sourcing
      • 5.4.1.1. Global Comparator Drug Sourcing Market, by Local Sourcing, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Global Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
  • 5.5. Other Types
      • 5.5.1.1. Global Comparator Drug Sourcing Market, by Other Types, by Region, 2020-2034 (USD Billion)

6. Global Comparator Drug Sourcing Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Drug Producers/Manufacturers
    • 6.3.1. Global Comparator Drug Sourcing Market, by Drug Producers/Manufacturers, by Region, 2020-2034 (USD Billion)
  • 6.4. Contract Manufacturing Organizations (CMO)
    • 6.4.1. Global Comparator Drug Sourcing Market, by Contract Manufacturing Organizations (CMO), by Region, 2020-2034 (USD Billion)
  • 6.5. Academic and Research Institute
    • 6.5.1. Global Comparator Drug Sourcing Market, by Academic and Research Institute, by Region, 2020-2034 (USD Billion)
  • 6.6. Other Applications
    • 6.6.1. Global Comparator Drug Sourcing Market, by Other Applications, by Region, 2020-2034 (USD Billion)

7. Global Comparator Drug Sourcing Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Comparator Drug Sourcing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Comparator Drug Sourcing Market - North America
    • 7.3.1. North America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
    • 7.3.2. North America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.3.3. Comparator Drug Sourcing Market - U.S.
      • 7.3.3.1. U.S.: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.3.4. Comparator Drug Sourcing Market - Canada
      • 7.3.4.1. Canada: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • 7.4. Comparator Drug Sourcing Market - Europe
    • 7.4.1. Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.3. Comparator Drug Sourcing Market - UK
      • 7.4.3.1. UK: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.4. Comparator Drug Sourcing Market - France
      • 7.4.4.1. France: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.5. Comparator Drug Sourcing Market - Germany
      • 7.4.5.1. Germany: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.6. Comparator Drug Sourcing Market - Italy
      • 7.4.6.1. Italy: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.7. Comparator Drug Sourcing Market - Spain
      • 7.4.7.1. Spain: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.8. Comparator Drug Sourcing Market - Netherlands
      • 7.4.8.1. Netherlands: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.9. Comparator Drug Sourcing Market - Russia
      • 7.4.9.1. Russia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.4.10. Comparator Drug Sourcing Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • 7.5. Comparator Drug Sourcing Market - Asia Pacific
    • 7.5.1. Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.3. Comparator Drug Sourcing Market - China
      • 7.5.3.1. China: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.4. Comparator Drug Sourcing Market - India
      • 7.5.4.1. India: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.5. Comparator Drug Sourcing Market - Malaysia
      • 7.5.5.1. Malaysia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.6. Comparator Drug Sourcing Market - Japan
      • 7.5.6.1. Japan: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.7. Comparator Drug Sourcing Market - Indonesia
      • 7.5.7.1. Indonesia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.8. Comparator Drug Sourcing Market - South Korea
      • 7.5.8.1. South Korea: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.9. Comparator Drug Sourcing Market - Australia
      • 7.5.9.1. Australia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.5.10. Comparator Drug Sourcing Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • 7.6. Comparator Drug Sourcing Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.6.3. Comparator Drug Sourcing Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.6.4. Comparator Drug Sourcing Market - UAE
      • 7.6.4.1. UAE: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.6.5. Comparator Drug Sourcing Market - Israel
      • 7.6.5.1. Israel: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.6.6. Comparator Drug Sourcing Market - South Africa
      • 7.6.6.1. South Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.6.7. Comparator Drug Sourcing Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
  • 7.7. Comparator Drug Sourcing Market - Latin America
    • 7.7.1. Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.7.3. Comparator Drug Sourcing Market - Mexico
      • 7.7.3.1. Mexico: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.7.4. Comparator Drug Sourcing Market - Brazil
      • 7.7.4.1. Brazil: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.7.5. Comparator Drug Sourcing Market - Argentina
      • 7.7.5.1. Argentina: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)
    • 7.7.6. Comparator Drug Sourcing Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Comparator Drug Sourcing Market, by Type, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Comparator Drug Sourcing Market, by Application, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alcura
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. ADAllen Pharma
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. BAP Pharma Limited
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Bionical Emas
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Catalent, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Cencora, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Clinical Services International (CSI)
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Clinigen Limited
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Inceptua Group
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Myonex
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Oximio
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. RxSolutions division
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Sharp Services, LLC
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Thermo Fisher Scientific Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Uniphar Clinical
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development